- Home
- C vs BSX Comparison
C vs BSX Comparison
Compare C & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | C | BSX |
|---|---|---|
| Founded | 1812 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 181.0B | 149.7B |
| IPO Year | N/A | 1992 |
Fundamental Metrics
Financial Performance| Metric | C | BSX |
|---|---|---|
| Price | $109.20 | $92.71 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 19 |
| Target Price | $104.43 | ★ $124.53 |
| AVG Volume (30 Days) | ★ 11.4M | 9.5M |
| Earning Date | 01-14-2026 | 10-22-2025 |
| Dividend Yield | ★ 2.19% | N/A |
| EPS Growth | ★ 103.93 | 54.68 |
| EPS | ★ 7.10 | 1.87 |
| Revenue | ★ $75,384,000,000.00 | $19,349,000,000.00 |
| Revenue This Year | $23.16 | $21.05 |
| Revenue Next Year | $3.03 | $11.43 |
| P/E Ratio | ★ $15.40 | $49.48 |
| Revenue Growth | 9.24 | ★ 21.61 |
| 52 Week Low | $55.51 | $85.98 |
| 52 Week High | $110.25 | $109.50 |
Technical Indicators
Market Signals| Indicator | C | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 71.36 | 30.97 |
| Support Level | $102.41 | $100.50 |
| Resistance Level | $110.25 | $101.91 |
| Average True Range (ATR) | 2.55 | 2.23 |
| MACD | 0.90 | -0.76 |
| Stochastic Oscillator | 94.31 | 2.54 |
Price Performance
Historical ComparisonAbout C Citigroup Inc.
Citigroup is a global financial-services company doing business in more than 100 countries and jurisdictions. Citigroup's operations are organized into five primary segments: services, markets, banking, US personal banking, and wealth management. The bank's primary services include cross-border banking needs for multinational corporates, investment banking and trading, and credit card services in the United States.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.